Lynn Seely

Director, President and CEO · 2 filings · Latest: Feb 11, 2026

Lyell Immunopharma, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
LYEL	Lynn Seely	Director, President and CEO	Feb 11, 2026	Sale	$23.39	7,455	$174.4K	74,266	Feb 13 1:47 AM
LYEL	Lynn Seely	Director, President and CEO	Feb 10, 2026	Sale	$23.12	438	$10.1K	81,721	Feb 12 2:03 AM